REPRO MED SYSTEMS, INC. (OTCMKTS:REPR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ME Staff 8-k
-
0

REPRO MED SYSTEMS, INC. (OTCMKTS:REPR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY
ARRANGEMENTS OF CERTAIN OFFICERS.

Appointment of Executive Officer

On January 17, 2017, Repro Med Systems, Inc. dba RMS Medical
Products (RMS) hired Mr. Eric Bauer as its Chief Operating
Officer, effective immediately.

Mr. Bauer, age 60, has more than 25 years of executive management
experience in a variety of manufacturing and FDA regulated
industries. Prior to joining RMS Medical Products, Mr. Bauer was
Chief Executive Officer of 2020Value, LLC, a consulting and
coaching business, from 2015 to 2017. He assisted clients with
maximizing long-term sustainable value by focusing on people,
processes and products. He established operational excellence
supported through strategic initiatives to bring significant
EBITDA growth with highly efficient teams for client
organizations. From 2011 to 2015, Mr. Bauer served in the role of
Chief Executive Officer for KAKO Beauty Products, consisting of
the development of prestige skin care goods together with
designing, packaging, marketing and implementation of a channel
distribution strategy. From 2008 to 2011, Mr. Bauer was Chief
Executive Officer of Chemaid Laboratories, a Private Equity-owned
contract manufacturing company providing high quality skin care,
haircare, fragrance and bath products to the prestige cosmetics
industry. At Chemaid, Mr. Bauer implemented innovations with the
highest quality approach. With PL responsibility, he presided
over the Company instilling his strategic vision, maximizing
long-term shareholder value, which doubled revenue growth with a
significant increase in EBITDA and pioneered cultural change in
the Company.

Compensatory Arrangements

On January 17, 2017 (the Effective Date), RMS and Mr. Bauer
entered into an employment agreement. The following summary of
the employment agreement does not purport to be complete and is
subject to and qualified in its entirety by the terms of the
employment agreement.

The material terms of the agreement are as follows:

Mr. Bauers annual base compensation will be $275,000.

Mr. Bauer will receive a one-time sign on bonus of $25,000
payable upon hire.

Mr. Bauer shall be eligible to earn an annual bonus in
accordance with the Company policy and procedure for
granting of a specified executive bonus which is equivalent
to 50% of base compensation based on achievement of goals,
payable 50% in cash and 50% in stock of the Company.

Mr. Bauer will receive a sign-on stock option grant of
500,000 incentive stock options that vest quarterly over a
four year term and in accordance with the Companys current
stock option plan. Vesting is automatically accelerated if
Mr. Bauers employment is terminated by the Company without
Cause (as defined in the employment agreement) after two
years of employment.

Mr. Bauer will receive up to $35,000 in expense
reimbursement to cover costs attributable to relocation to
the Chester, NY area. Mr. Bauer will also receive $2,000
per month to cover the cost of temporary housing for up to
twelve (12) months from Effective Date or until Executive
relocates.

The term of the employment is one year from the Effective
Date, subject to automatic renewals unless 60 days notice
of non-renewal is provided by the Company or Mr. Bauer.

The Company or Mr. Bauer may terminate Mr. Bauers
employment at any time upon 60 days notice to the other,
and the Company may terminate his employment agreement
immediately for Cause.

Upon termination of Mr. Bauers employment by the Company
without Cause, subject to his execution of a customary
general release of claims in favor of the Company and its
affiliates, Mr. Bauer is be entitled to receive an amount
equal to (i) if the termination date is less than twelve
(12) months after the Effective Date, six months of the
cash portion (but not the stock portion) of his salary; or
(ii) if the termination date is at least twelve (12) months
after the Effective Date, twelve (12) months of the cash
portion (but not the stock portion) of his salary.

– 2 –


About REPRO MED SYSTEMS, INC. (OTCMKTS:REPR)

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator. The FREEDOM60 consists of the FREEDOM60 Syringe Infusion Pump and RMS Precision Flow Rate Tubing. The HIgH-Flo is designed for self-administration of medicine under the skin. The RES-Q-VAC is a hand-operated suction device that removes fluids from a patient’s airway by attaching the RES-Q-VAC pump to various sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The On-Line Calculator is a tool to help determine which of the Company’s Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Needle Sets are to be used based on the medication being administered and time of infusion.

REPRO MED SYSTEMS, INC. (OTCMKTS:REPR) Recent Trading Information

REPRO MED SYSTEMS, INC. (OTCMKTS:REPR) closed its last trading session up +0.010 at 0.420 with 5,500 shares trading hands.